Antidiabetic oxazolidinediones and thiazolidinediones

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/12 (2006.01) A61K 31/4439 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2612984

Pyridinyloxyphenyl and pyridinyloxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones are agonists or par-tial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

Les pyridinyloxyphényl et pyridinyloxybenzyl oxazolidine-2,4-diones et thiazolidine-2,4-diones selon l'invention sont des agonistes ou des agonistes partiels de PPAR gamma et sont utiles dans le traitement et la régulation de l'hyperglycémie qui est symptomatique du diabète de type II, ainsi que de la dyslipidémie, de l'hyperlipidémie, de l'hypercholestérolémie, de l'hypertriglycéridémie et de l'obésité qui sont souvent associées au diabète de type 2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antidiabetic oxazolidinediones and thiazolidinediones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antidiabetic oxazolidinediones and thiazolidinediones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidiabetic oxazolidinediones and thiazolidinediones will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1721514

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.